0000927066-19-000120.txt : 20190621
0000927066-19-000120.hdr.sgml : 20190621
20190621184637
ACCESSION NUMBER: 0000927066-19-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190619
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waters Kathleen Alyce
CENTRAL INDEX KEY: 0001640409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 19912767
MAIL ADDRESS:
STREET 1: C/O HEALTH NET, INC.
STREET 2: 21650 OXNARD STREET
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wf-form4_156115718275765.xml
FORM 4
X0306
4
2019-06-19
0
0000927066
DAVITA INC.
DVA
0001640409
Waters Kathleen Alyce
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Chief Legal Officer
Common Stock
2019-06-19
4
A
0
33148
0
A
59663
D
Common Stock
2019-06-19
4
F
0
8425
0
D
51238
D
Stock Appreciation Rights
52.41
2019-06-20
4
A
0
80000
0
A
2024-06-20
Common Stock
80000.0
80000
D
Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 28, 2018, in which 16,574 shares vested on June 19, 2019, and the remaining 16,574 vest on December 19, 2020.
Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 16,574 shares as described in footnote 1 above.
The stock appreciation rights are scheduled to vest 50% on each of June 20, 2022 and June 20, 2023, respectively, subject to the terms and conditions of the applicable award agreement.
/s/ James K. Hilger, Attorney-in-Fact
2019-06-21